Bias, Spin, and Misreporting: Time for Full Access to Trial Protocols and Results

1. McHenryLBJureidiniJN

2008

Industry-sponsored ghostwriting in clinical trial reporting: A case study.

Account Res

15

152

167

2. JureidiniJNMcHenryLBMansfieldPR

2008

Clinical trials and drug promotion: Selective reporting of study 329.

Int J Risk Safety Med

20

73

81

3. PsatyBMKronmalRA

2008

Reporting mortality findings in trials of rofecoxib for Alzheimer disease or cognitive impairment: A case study based on documents from rofecoxib litigation.

JAMA

299

1813

1817

4. CurfmanGDMorrisseySDrazenJM

2006

Expression of concern reaffirmed.

N Engl J Med

354

1193

5. WhittingtonCJKendallTFonagyPCottrellDCotgroveA

2004

Selective serotonin reuptake inhibitors in childhood depression: Systematic review of published versus unpublished data.

Lancet

363

1341

1345

6. DwanKAltmanDGArnaizJABloomJChanA-W

2008

Systematic review of the empirical evidence of study publication bias and outcome reporting bias.

PLoS ONE

3

e3081

doi:10.1371/journal.pone.0003081

7. SongFEastwoodAJGilbodySDuleyLSuttonAJ

2000

Publication and related biases.

Health Technol Assess

4

1

115

8. DickersinK

1997

How important is publication bias? A synthesis of available data.

AIDS Educ Prev

9

15

21

9. RisingKBacchettiPBeroL

2008

Reporting bias in drug trials submitted to the Food and Drug Administration: A review of publication and presentation.

PLoS Med

5

e217

doi:10.1371/journal.pmed.0050217

10. TurnerEHMatthewsAMLinardatosETellRARosenthalR

2008

Selective publication of antidepressant trials and its influence on apparent efficacy.

N Engl J Med

358

252

260

11. MelanderHAhlqvist-RastadJMeijerGBeermannB

2003

Evidence b(i)ased medicine—Selective reporting from studies sponsored by pharmaceutical industry: Review of studies in new drug applications.

BMJ

326

1171

1173

12. HemminkiE

1980

Study of information submitted by drug companies to licensing authorities.

BMJ

280

833

836

13. ChanA-WHróbjartssonAJørgensenKJGøtzschePCAltmanDG

2008

Discrepancies in sample size calculations and data analyses reported in randomized trials: Comparison of publications with protocols.

BMJ

In press

14. ChanA-WHróbjartssonAHaahrMTGøtzschePCAltmanDG

2004

Empirical evidence for selective reporting of outcomes in randomized trials: Comparison of protocols to published articles.

JAMA

291

2457

2465

15. HahnSWilliamsonPRHuttonJL

2002

Investigation of within-study selective reporting in clinical research: Follow-up of applications submitted to a local research ethics committee.

J Eval Clin Pract

8

353

359

16. PildalJChanA-WHróbjartssonAForfangEAltmanDG

2005

Does unclear allocation concealment in trial publications reflect poor methods or poor reporting of adequate methods? Cohort study of trial protocols and corresponding published reports.

BMJ

330

1049

1052

17. ChanA-WKrleža-JericKSchmidIAltmanDG

2004

Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research.

CMAJ

171

735

740

18. ScharfOColevasAD

2006

Adverse event reporting in publications compared with sponsor database for cancer clinical trials.

J Clin Oncol

24

3933

3938

19. SoaresHPDanielsSKumarAClarkeMScottC

2004

Bad reporting does not mean bad methods for randomised trials: Observational study of randomised controlled trials performed by the Radiation Therapy Oncology Group.

BMJ

328

22

24

20. Al-MarzoukiSRobertsIEvansSMarshallT

2008

Selective reporting in clinical trials: Analysis of trial protocols accepted by The Lancet.

Lancet

372

201

21. LeeKBacchettiPSimI

2008

Publication of clinical trials supporting successful new drug applications: A literature analysis.

PLoS Med

5

e191

doi:10.1371/journal.pmed.0050191

22. MorganSGBassettKLWrightJMEvansRGBarerML

2005

“Breakthrough” drugs and growth in expenditure on prescription drugs in Canada.

BMJ

331

815

816

23. TurnerEH

2004

A taxpayer-funded clinical trials registry and results database.

PLoS Med

1

e60

doi:10.1371/journal.pmed.0010060

24. ChanA-WAltmanDG

2005

Epidemiology and reporting of randomised trials published in PubMed journals.

Lancet

365

1159

1162

25. ChanA-WUpshurRSinghJAGhersiDChapuisF

2006

Research protocols: Waiving confidentiality for the greater good.

BMJ

332

1086

1089

26. LuriePZieveA

2008

Sometimes the silence can be like the thunder: Access to pharmaceutical data at the FDA.

Law Contemporary Problems

69

85

97

27. ChanA-WTetzlaffJAltmanDGGøtzschePCHróbjartssonA

2008

The SPIRIT initiative: Defining Standard Protocol Items for Randomized Trials [conference abstract].

German J Evid Quality Health Care (suppl)

102

S27

28. World Health Organization

2008

International Clinical Trials Registry Platform.

Available: http://www.who.int/ictrp/en/. Accessed 20 October 2008

29. The PLoS Medicine Editors

2008

Next stop, don't block the doors: Opening up access to clinical trials results.

PLoS Med

5

e160

doi:10.1371/journal.pmed.0050160

30. United States Congress

2007

Food and Drug Administration Amendments Act of 2007, Title VIII, Section 801. Expanded clinical trial registry data bank.

Available: http://www.govtrack.us/congress/billtext.xpd?bill=h110-3580. Accessed 20 October 2008

31. SimIChanA-WGulmezogluAMEvansTPangT

2006

Clinical trial registration: Transparency is the watchword.

Lancet

367

1631

1633

32. DeAngelisCDDrazenJMFrizelleFAHaugCHoeyJ

2005

Is this clinical trial fully registered?: A statement from the International Committee of Medical Journal Editors.

JAMA

293

2927

2929

33. Krleža-JericKChanA-WDickersinKSimIGrimshawJ

2005

Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1).

BMJ

330

956

958

34. PLoS Medicine

2008

Guidelines for authors.

Available: http://journals.plos.org/plosmedicine/guidelines.php#supporting. Accessed 20 October 2008

35. McNameeDJamesAKleinertS

2008

Protocol review at The Lancet.

Lancet

372

189

190

36. JonesGAbbasiK

2004

Trial protocols at the BMJ.

BMJ

329

1360

37. LassereMJohnsonK

2002

The power of the protocol.

Lancet

360

1620

1622

38. HawkeyCJ

2001

Journals should see original protocols for clinical trials.

BMJ

323

1309

39. MitkaM

2008

Controversies surround heart drug study: Questions about Vytorin and trial sponsors' conduct.

JAMA

299

885

887